Suppr超能文献

肾激肽拮抗作用不会损害压力诱导的利钠作用。

Renal kinin antagonism does not impair pressure-induced natriuresis.

作者信息

Strick D M, Fiksen-Olsen M J, Carretero O A, Romero J C

机构信息

Department of Physiology and Biophysics, Mayo School of Medicine, Mayo Clinic, Rochester, Minnesota 55905.

出版信息

Am J Physiol. 1992 Jul;263(1 Pt 2):F77-82. doi: 10.1152/ajprenal.1992.263.1.F77.

Abstract

We studied the contribution of the renal kallikrein-kinin system to short-term electrolyte and water balance during baseline and during acutely elevated renal perfusion pressure (RPP) in the anesthetized dog. Renal blood flow, glomerular filtration rate, urine flow rate, renin secretion rate, and urinary excretion of sodium, potassium, prostaglandin E2 (PGE2), and kinins were measured at baseline RPP during intrarenal infusion of 0.9% saline or the competitive bradykinin analogue [D-Arg0,Hyp3,Thi5,D-Phe7,Thi8]bradykinin (50 micrograms/min), which blocks vascular and interstitial kinin receptors. RPP was then raised above baseline (control group 25%; kinin analogue group 22%) by ligating the celiac artery, the superior mesenteric artery, and the aorta distal to the renal arteries. Renal parameters were again measured during infusion of saline or the kinin analogue. The analogue had no effect on renal hemodynamic or excretory parameters at baseline perfusion pressures. Increasing RPP significantly increased urine flow rates and urinary sodium excretion rates (control group, 43 mumol/min; kinin analogue group, 55 mumol/min) in both groups of animals. Increasing pressure also tended to decrease renin secretion rate in both groups of animals; however, neither increased pressure nor infusion of the analogue affected urinary excretion of PGE2 or kinins. The results suggest that intrarenal kinins are not powerful short-term regulators of electrolyte and water balance and that an intact kallikrein-kinin system is not necessary to induce pressure diuresis and natriuresis.

摘要

我们研究了肾激肽释放酶-激肽系统在麻醉犬的基线期以及肾灌注压(RPP)急性升高期间对短期电解质和水平衡的作用。在肾内输注0.9%生理盐水或竞争性缓激肽类似物[D-Arg0,Hyp3,Thi5,D-Phe7,Thi8]缓激肽(50微克/分钟)期间,于基线RPP时测量肾血流量、肾小球滤过率、尿流率、肾素分泌率以及钠、钾、前列腺素E2(PGE2)和激肽的尿排泄量,该缓激肽类似物可阻断血管和间质激肽受体。然后通过结扎腹腔动脉、肠系膜上动脉以及肾动脉远端的主动脉,使RPP升高至基线以上(对照组升高25%;激肽类似物组升高22%)。在输注生理盐水或激肽类似物期间再次测量肾脏参数。该类似物在基线灌注压时对肾脏血流动力学或排泄参数无影响。在两组动物中,RPP升高均显著增加了尿流率和尿钠排泄率(对照组为43微摩尔/分钟;激肽类似物组为55微摩尔/分钟)。压力升高也往往会降低两组动物的肾素分泌率;然而,压力升高和输注类似物均未影响PGE2或激肽的尿排泄。结果表明,肾内激肽并非电解质和水平衡的强大短期调节因子,完整的激肽释放酶-激肽系统对于诱导压力性利尿和利钠作用并非必需。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验